85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

71 trials found

diseases per page:

Showing 1 to 10 of 71 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05195918 (ClinicalTrials.gov)	March 1, 2023	2/12/2021	Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients	Dose Ranging Study of Oral Epigallocatechin-3-gallate (EGCG) Given Daily for 12 Weeks to Patients Wi ...	Idiopathic Pulmonary Fibrosis	Combination Product: EGCG 300 mg + Nintedanib;Combination Product: EGCG 300 mg + Pirfenidone;Combina ...	Hal Chapman	University of Michigan;Cornell University;Massachusetts General Hospital;Temple University;Universit ...	Not yet recruiting	40 Years	85 Years	All	50	Phase 1	United States
2	NCT05373914 (ClinicalTrials.gov)	May 31, 2022	10/5/2022	RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) ...	RESPIRARE - A Phase 2, Randomized, Double-blinded, Placebo-controlled, Efficacy and Safety Study of ...	Idiopathic Pulmonary Fibrosis	Drug: Cudetaxestat (BLD-0409);Drug: Control: Matching Placebo	Blade Therapeutics	NULL	Not yet recruiting	40 Years	85 Years	All	200	Phase 2	NULL
3	NCT04888715 (ClinicalTrials.gov)	July 23, 2021	28/4/2021	To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanibin Healthy Voluntee ...	An Open Label, 2-part, One-sequence, 3-period Study to Evaluate Drug-drug Interactions Between DWN12 ...	Idiopathic Pulmonary Fibrosis	Drug: DWN12088;Drug: Pirfenidone;Drug: Nintedanib	Daewoong Pharmaceutical Co. LTD.	NULL	Completed	19 Years	55 Years	All	48	Phase 1	Korea, Republic of
4	NCT05383131 (ClinicalTrials.gov)	June 23, 2021	12/5/2022	To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanibin Healthy Volunteers ...	A Single Center, Open Label Study to Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone ...	Idiopathic Pulmonary Fibrosis	Drug: HEC585;Drug: Pirfenidone;Drug: Nintedanib	Sunshine Lake Pharma Co., Ltd.	NULL	Completed	18 Years	45 Years	All	33	Phase 1	China
5	NCT04739150 (ClinicalTrials.gov)	March 29, 2021	1/2/2021	An Expanded Access Program in Belgium to Provide Nintedanibto People With Lung Diseases Called Non-I ...	Medical Need Program With Ofev® (Nintedanib) for the Treatment of Adult Patients With Non-IPF (Idiop ...	Lung Diseases, Interstitial	Drug: nintedanib	Boehringer Ingelheim	NULL	No longer available	18 Years	N/A	All			Belgium
6	JPRN-jRCT2031210008	27/01/2021	02/04/2021	A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary F ...	A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-center Study to Evalu ...	Idiopathic Pulmonary Fibrosis	This clinical Phase 3 study is a randomized, double-blind, parallel-group, placebo-controlled multic ...	Kayamori Takefumi	NULL	Not Recruiting	>= 40age old	Not applicable	Both	49	Phase 3	Japan;USA;Denmark;Peru;Australia;Germany;Taiwan;Belgium;Greece;Brazil;Spain;Chile;United Kingdom;Cze ...
7	NCT04525547 (ClinicalTrials.gov)	January 13, 2021	21/8/2020	Safety and Effectiveness of Nintedanib in Korean Patients	A Regulatory Required Non-interventional Study to Monitor the Safety and Effectiveness of Ofev(Ninte ...	Idiopathic Pulmonary Fibrosis	Drug: Nintedanib	Boehringer Ingelheim	NULL	Completed	N/A	N/A	All	70		Korea, Republic of
8	NCT04614441 (ClinicalTrials.gov)	December 25, 2020	29/10/2020	NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of Pe ...	Non-Interventional Collecting Evidences For ILD in Taiwan: Optimized Novel Therapy	Idiopathic Pulmonary Fibrosis	Drug: OFEV®	Boehringer Ingelheim	NULL	Active, not recruiting	20 Years	N/A	All	214		Taiwan
9	NCT03939520 (ClinicalTrials.gov)	June 11, 2020	3/5/2019	Management of Progressive Disease in Idiopathic Pulmonary Fibrosis	Pragmatic Management of Progressive Disease in Idiopathic Pulmonary Fibrosis: a Randomized Trial	Progressive Idiopathic Pulmonary Fibrosis	Drug: pirfenidone and nintedanib;Drug: pirfenidone or nintedanib	Hospices Civils de Lyon	NULL	Recruiting	50 Years	N/A	All	378	Phase 4	France
10	EUCTR2019-004326-19-FR (EUCTR)	27/01/2020	13/11/2019	Management of Progressive Disease in Idiopathic Pulmonary Fibrosis	Pragmatic management of progressive disease in idiopathic pulmonary fibrosis: a randomized trial - P ...	Idiopathic pulmonary fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idio ...	Trade Name: pirfenidone INN or Proposed INN: PIRFENIDONE Trade Name: nintedanib Other descriptive name: ...	Hospices Civils de Lyon	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	378	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France

First Previous1 2 3 4 5…8Next Last